menu
    • menu

    Company profile for Longeveron

    NEW Drugs in Dev: 6
    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

    Virtual Booth

    Contact Supplier

    AbbVie Contract Manufacturing partners globally to develop, scale, and manufacture pharmaceutical products successfully.

    Virtual Booth

    Contact Supplier

    Topscience Biotech is a one-stop supplier of sodium hyaluronate//drug manufacturing license, CEP, GMP, DMF, and Form 41 certifications.

    Virtual Booth

    Contact Supplier

    Zach System is committed to providing Highly Customized Solutions for all your Development Programs.

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Longeveron is a life-sciences company developing biological solutions for aging and aging-associated diseases. We believe regenerative medicine, through cell-based therapy, is a promising new approach to treating these conditions. Participating in FDA-evaluated clinical trials, we are currently testing our cell-based therapy product for a diagnosable ailment called Aging Frailty, a growing condition impacting approximately 50 ...
    Longeveron is a life-sciences company developing biological solutions for aging and aging-associated diseases. We believe regenerative medicine, through cell-based therapy, is a promising new approach to treating these conditions. Participating in FDA-evaluated clinical trials, we are currently testing our cell-based therapy product for a diagnosable ailment called Aging Frailty, a growing condition impacting approximately 50 million Americans over the age of 60.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    LongeveronUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    1951 NW 7TH AVENUE SUITE 520 MIAMI, FL 33136
    Telephone
    Telephone
    305.909.0840
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.longeveron.com/
    Linkedin
    Linkedin
    https://in.linkedin.com/company/longeveron-llc
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    PEGS Boston Summit

    PEGS Boston Summit

    Not Confirmed

    envelop Contact Supplier

    PEGS Boston Summit

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Longeveron to Present at BIO International Convention 2026
    Longeveron to Present at BIO International Convention 2026

    04 Jun 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/06/04/3306852/0/en/longeveron-to-present-at-bio-international-convention-2026.html

    GLOBENEWSWIRE
    04 Jun 2026
    Share Share
    Longeveron Issues Letter Highlighting 2026 Corporate Strategy
    Longeveron Issues Letter Highlighting 2026 Corporate Strategy

    20 May 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/05/20/3298860/0/en/longeveron-issues-letter-to-stockholders-highlighting-corporate-strategy-strategic-partnering-approach-and-2026-key-priorities.html

    GLOBENEWSWIRE
    20 May 2026
    Share Share
    Longeveron Reveals 2026 Q1 Financials And Business Update
    Longeveron Reveals 2026 Q1 Financials And Business Update

    13 May 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/05/13/3294435/0/en/longeveron-announces-2026-first-quarter-financial-results-and-provides-business-update.html

    GLOBENEWSWIRE
    13 May 2026
    Share Share
    Longeveron IDMC Backs Completing Phase 2b Stem Cell Trial in HLHS
    Longeveron IDMC Backs Completing Phase 2b Stem Cell Trial in HLHS

    11 May 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/05/11/3291965/0/en/longeveron-announces-independent-data-monitoring-committee-positive-review-and-recommendation-to-complete-phase-2b-stem-cell-therapy-clinical-trial-in-hypoplastic-left-heart-syndro.html

    GLOBENEWSWIRE
    11 May 2026
    Share Share
    Longeveron Has Positive FDA Type C Meeting Before ELPIS II Data
    Longeveron Has Positive FDA Type C Meeting Before ELPIS II Data

    08 May 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/05/08/3291328/0/en/longeveron-announces-constructive-type-c-meeting-with-u-s-fda-ahead-of-data-readout-for-elpis-ii-phase-2b-clinical-trial-evaluating-treatment-for-hypoplastic-left-heart-syndrome-hl.html

    GLOBENEWSWIRE
    08 May 2026
    Share Share
    Longeveron Reports Q1 2026 Results, Call on May 13
    Longeveron Reports Q1 2026 Results, Call on May 13

    05 May 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/05/05/3288288/0/en/longeveron-to-report-2026-first-quarter-financial-results-and-host-conference-call-on-may-13-2026.html

    GLOBENEWSWIRE
    05 May 2026
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search